The company's products, such as Dipeptidyl and Peptidase IV inhibitor, target tissue remodeling pathways for diseases like rheumatoid arthritis, liver fibrosis, cardiovascular, chronic wound healing, and cancer. Founded in 2002 and based in Cambridge, Massachusetts, Alantos Pharmaceuticals is committed to discovering and developing innovative drugs to improve patients' lives.